Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Pontifax Management 4 G.P. (2015) Ltd. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Deep Track Biotechnology Master Fund, Ltd. - $20.00M in LBRX purchases and sales in the last 12 months
- Esther Cho - $124K in KROS purchases and sales in the last 12 months
- Jasbir Seehra - $113K in KROS purchases and sales in the last 12 months
- Lorena Raquel Lerner - $100K in KROS purchases and sales in the last 12 months
- Keith Regnante - $77K in KROS purchases and sales in the last 12 months
- Jean Jacques Bienaime - $76K in KROS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Pontifax Management 4 G.P. (2015) Ltd.?
Pontifax Management 4 G.P. (2015) Ltd. is an investment firm, tracked as 10% Owner of Keros Therapeutics, Inc. (KROS). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Pontifax Management 4 G.P. (2015) Ltd. last file a Form 4?
The most recent primary Form 4 on record is dated 15 October 2025, one of 2 filings going back to 2025.
Has Pontifax Management 4 G.P. (2015) Ltd. been buying or selling stock?
Recorded transactions: 1 open-market purchase ($15.00M) and 4 open-market sales ($84.98M) across all tracked filings.
